Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab

There are an increasing number of treatments available for multiple sclerosis (MS). The early identification of optimal responders to individual treatments is important to achieve individualized therapy. With this aim, we performed a multicenter retrospective longitudinal study including 186 MS pati...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Rep
Huvudupphovsmän: Dominguez-Mozo, Maria Inmaculada, Perez-Perez, Silvia, Villar, Luisa María, Oliver-Martos, Begoña, Villarrubia, Noelia, Matesanz, Fuencisla, Costa-Frossard, Lucienne, Pinto-Medel, María Jesús, García-Sánchez, María Isabel, Ortega-Madueño, Isabel, Lopez-Lozano, Lorena, Garcia-Martinez, Angel, Izquierdo, Guillermo, Fernández, Óscar, Álvarez-Cermeño, Jose Carlos, Arroyo, Rafael, Alvarez-Lafuente, Roberto
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group UK 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7455689/
https://ncbi.nlm.nih.gov/pubmed/32859922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-71283-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk